Biotechnology is leading the most important scientific revolution since computing. R&D is the key to unleashing biotechnology's potential to transform our world radically, but software hasn't kept up with science. Scientists deserve and urgently need technology that's designed for what they do. But I invited Paul Robson to join me on the podcast to discuss how Benchling R&D Cloud is built for scientific work.

We talk about the shortcomings currently present within life sciences R&D that inspired its creation and the role of the cloud, and how its transforming R&D in life sciences to speed up scientific discoveries, including Covid-19 research.

About Paul

Paul Robson is Head of Field Operations at Benchling, overseeing all aspects of global sales, from deployment and customer success to strategic partnerships and regional expansion. Paul brings more than 25 years of experience scaling high-performing field organizations.

Most recently, as President of International at Adobe, he led global business across 160 countries. He joined Adobe in 2011 and played a key role in the company's transformation from packaged desktop software to a cloud subscription model. Prior to Adobe, Paul held leadership roles at Hewlett-Packard and Compaq.

Paul is an advisory member on Telecoms and Technology for UK Trade & Investment and board member of techUK. Originally from Australia, Paul graduated from Western Sydney University and holds graduate degrees from INSEAD and University of Helsinki.